Metrics Webinar: Addressing containment, regulatory and manufacturing challenges in high potency drug development
28 October | 11:00AM EST
Why Attend:
Highly potent drugs are becoming increasingly prevalent in the drug development pipeline. The focus on oncology, rare diseases and highly targeted therapies is growing. While highly potent compounds have benefits in treating certain medical conditions, companies with promising high potency active pharmaceutical ingredients (HPAPIs) can face significant challenges in developing and bringing these innovative medicines to market. Key challenges revolve around containment systems that ensure workers and the environment are protective along with demonstrable and adequate controls to mitigate cross-contamination risks in a multi-purpose environment.
Some drug sponsors/developers do not always understand what potency implies or what it means to their proposed processes at a selected CDMO site. They may not know how much or what type of containment is needed and its impact to the development, scale-up, and/or commercial manufacturing processes.
This webinar will examine:
Do you have a containment challenge involving HPAPIs? Are you wondering how your potent compound will be contained at a contractor site and its impacts on your project moving forward?Join this engaging webinar as presenters explore containment issues and provide examples and information from years of real-world experience in handling high potency products.
Key Learning Objectives
Speakers:
We hope to see you there! Contact us with any questions.
Hosted by Business Review Webinars
